期刊文献+

奥美拉唑对大鼠反流性食管黏膜损伤后细胞增殖相关基因表达的影响 被引量:4

Effects of omeprazole on the esophageal mucosal cell proliferation and expressions of related genes in rats
下载PDF
导出
摘要 目的观察奥美拉唑对反流性管黏膜损伤后细胞增殖相关基因表达的影响。方法健康雄性SD大鼠随机分为5组,假手术组、单纯胃食管反流动物模型组(模型组)、模型组+奥美拉唑低剂量组、中剂量组、高剂量组,每组15只。分别取食管标本肉眼观察黏膜状况,HE染色,光镜观察组织病理学变化,应用免疫组化染色等方法检测p21,PCNA,CyclinD1,CDK4的表达情况。结果假手术组大鼠食管颜色淡红,有光泽,黏膜光滑。模型组大鼠食管颜色变淡白,黏膜粗糙、增厚、皱襞灰白色斑块状增生。与模型组比较,奥美拉唑低、中、高剂量治疗组大鼠食管病变明显减轻(P<0.05)。HE染色显示,假手术组大鼠食管各层结构完整,黏膜厚薄适中,黏膜基底膜清楚,各层细胞排列整齐,表面可见较少的角化。模型组大鼠黏膜层增厚,基底细胞层及棘细胞层细胞数目增多,角化层增厚,局部黏膜基底细胞层明显增生,部分黏膜组织向外呈乳头样突起。与模型组比较,奥美拉唑治疗组大鼠食管黏膜损伤及增生病变明显减轻(P<0.05)。免疫组织化学检测显示,假手术组大鼠食管黏膜有p21蛋白表达,PCNA,CyclinD1和CDK4蛋白呈阳性基础表达。模型组大鼠食管黏膜p21蛋白的表达减弱,PCNA,CyclinD1和CDK4蛋白表达显著增强(P<0.05)。奥美拉唑治疗组大鼠食管黏膜p21蛋白的表达增强,PCNA,CyclinD1和CDK4蛋白表达明显降低(P<0.05)。结论奥美拉唑抑制细胞增殖可能是其治疗反流性食管损伤的重要机制。 Objective To observe the effects of omeprazole on esophageal mucosal cell proliferation and expressions of related genes in rats with esophageal mucosal injury induced by reflux of acid.Methods Seventy-five healthy male SD rats,weighted 220~250g,were randomly divided into 5 groups: sham-operation group,model group ( simple gastroesophageal reflux model) ,omeprazole low-dose group,medium-dose group and high-dose group,with 15 rats in each group.The rat models of reflux esophagitis were induced by single acid reflux.The pathological changes of esophageal mucosal were examined by naked eye, HE staining and light microscopy.The expressions of p21, PCNA, CyclinD1 and CDK4 were detected by immunohistochemical staining,and the results were analyzed by HPIAS-1000 system.The data were statistically analyzed with SPSS10.0.Results The color of esophagus of rats was erythroid and lustrous, with glossy mucosal membranes in sham-operation group.As compared with that in sham-operation group,the esophagus presented light white and esophageal mucous membrane became rough, thickened, grey plaque-like proliferation in rats of model group.As compared with that in model group,the pathological changes of esophagus were significantly relieved in the three different doses omeprazole treatment groups ( P 〈0.05) .HE staining showed that the various layer structure of rat’ s esophagus was intact,the base membrane of mucosa was clear and cellular arrangement was orderly in sham-operation group.As compared with those in sham-operation group,the esophageal mucosa was thickened,the cell numbers were increased in basal cell layer and prickle cell layer,and the cuticulae layer was thickened and proliferated,with some mucosal tissue presenting nipple-like elevation in model group.As compared with those in model group,the pathological changes of esophageal mucosa were significantly alleviated in omeprazole treatment groups ( P 〈0.05 ) .The results by immunohistochemistry showed that there was positive expression of p21 and basic expression of PCNA, CyclinD1 and CDK4 in basal cell layer of esophageal mucous membrane in sham-operation group. However the expression of p21 was decreased,the expressions of PCNA,CyclinD1,CDK4 were significantly increased in model group ( P 〈0.05).As compared with those in model group,the expression of p21 was increased,and the expressions of PCNA,CyclinD1,CDK4 were significantly decreased in omeprazole treatment groups ( P 〈0.05).Conclusion Omeprazole can up-regulate the expression of p21 after reflux esophagus injury and down-regulate the expressions of PCNA,CyclinD1 and CDK4,moreover,its inhibition effect on cell proliferation may be important action mechanism in treatment of reflux esophagus injury.
出处 《河北医药》 CAS 2014年第22期3372-3375,共4页 Hebei Medical Journal
关键词 胃酸反流 反流性食管损伤 p21 PCNA CYCLIND1 CDK4 gastric acid reflux reflux esophagitis p21 PCNA CyclinD1 CDK4
  • 相关文献

参考文献10

二级参考文献23

  • 1雷贝拉唑多中心临床协作组.反流性食管炎患者的症状特征及雷贝拉唑治疗疗效的多中心评估[J].中华消化杂志,2005,25(6):363-365. 被引量:61
  • 2李艳梅,苏秉忠,宋建忠.胃食管反流病的症状评分及内镜下表现的对照研究[J].中华消化内镜杂志,2006,23(1):7-10. 被引量:45
  • 3郭同刚.奥美拉唑治疗反流性食管炎的疗效观察[J].中国厂矿医学,2006,19(4):321-322. 被引量:2
  • 4Jin X,Cancer Res,1995年,55卷,32页
  • 5Liang Y Y,Int J Caaancer,1995年,61期,611页
  • 6Rennecke J, Rehberger PA, Furstenberger G, et al. Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int J Cancer,1999,80:98-103.
  • 7Morawski K, Gabriel A, Namyslowski G, et al. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer. Eur Arch Otorhinolaryngol,1999,256:378-383.
  • 8Kuwano H, Sumiyoshi K, Nozoe T, et al. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions(AgNOR) and proliferating cell nuclear antigen(PCNA) in esophageal cancer. Eur J Surg Oncol,1995,21:369-373.
  • 9Hashimoto N, Tachibana M, Dhar DK, et al. Expression of p53 and RB proteins in squamous cell carcinoma of the esophagus: their relationship with clinicopathologic characteristics. Ann Surg Oncol,1999,6:489-494.
  • 10Prevo LJ, Sanchez CA, Galipeau PC, et al. p53-mutant clones and field effects in Barrett′s esophagus. Cancer Res,1999,59:4784-4787.

共引文献36

同被引文献36

  • 1陆星华,张泰昌.反流性食管炎诊断及治疗指南(2003年)[J].中华消化内镜杂志,2004,21(4):221-222. 被引量:829
  • 2陈灏珠.实用内科学,第12版.北京:人民卫生出版社,2006.2705.
  • 3Farhadi A,Fields J,Banan A,et a|. Reactive oxygen species: are they in- volved in the pathogenesis of GERD, Barret' s esophagus, and the latter' s progression toward esophageal cancer .9 Am J Gastroenterol,2002,97 : 22.
  • 4Pursnani KG, Mohiuddin MA, Geisinger KR, et al. Experimental study of acid burden and acute esophagitis. Br J Surg, 1998,85: 677.
  • 5Wetscher GJ, Hinder PR, Bagchi D, et al. Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci, 1995,40: 1292.
  • 6Tomita R, KUrosu Y, Munakata K. Relationship between nitric oxide and non-adrenergic non-cholinergic inhibitory nerves in human lower esopha- geal sphincter. Gastroenterol, 1997,32 : 1-5.
  • 7Soteras F, Lanas A, Fiteni I, et al. Nitric oxide and superqxide anion in low-grade esophagitis induced by acid and pepsin in rabbits. Dig Dis Sei, 2000,45 : 1802-1809.
  • 8Galmiche J P, Janssens J. The pathophysiology of gastroe- sophageal reflux disease : an overview [ J ]. Scand Gastroen- terol, 1995, 2(1): 71-77.
  • 9Pettit M. Treatment of gastroesophaheal reflux disease [ J ]. Pharm World Sci, 2005, 27 (6) : 432 - 437.
  • 10Pursnani K G, Mohiuddin M A, Geisinger K R, et al. Ex- perimental study of acid burned and acute oesophagitis [ J ]. Br Surg, 1998, 85(5) :677-682.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部